Have a feature idea you'd love to see implemented?
Let us know!
IGMS IGM Biosciences Inc
Price (delayed)
$17.955
Market cap
$1.07B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.64
Enterprise value
$1.04B
Headquartered in Mountain View, California, IGM Biosciences is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies. Since 2010, IGM Biosciences has worked to overcome the manufacturing
Highlights
IGMS's revenue has surged by 74% year-on-year and by 38% since the previous quarter
IGM Biosciences's gross profit has surged by 74% YoY and by 38% QoQ
IGM Biosciences's equity has plunged by 53% YoY and by 24% from the previous quarter
IGM Biosciences's quick ratio has decreased by 22% YoY and by 12% QoQ
Key stats
What are the main financial stats of IGMS
Market
Valuations
Earnings
Shares outstanding
59.32M
Market cap
$1.07B
Enterprise value
$1.04B
Price to earnings (P/E)
N/A
Price to book (P/B)
8.66
Price to sales (P/S)
372.76
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
356.3
Revenue
$2.91M
EBIT
-$219.92M
EBITDA
-$205.43M
Free cash flow
-$176.12M
Per share
Balance sheet
Liquidity
EPS
-$3.64
Free cash flow per share
-$2.91
Book value per share
$2.07
Revenue per share
$0.05
TBVPS
$5.57
Total assets
$336.5M
Total liabilities
$214.14M
Debt
$39.37M
Equity
$122.36M
Working capital
$228.36M
Debt to equity
0.32
Current ratio
7.06
Quick ratio
6.82
Net debt/EBITDA
0.14
Margins
Efficiency
Dividend
EBITDA margin
-7,057.1%
Gross margin
100%
Net margin
-7,571.4%
Operating margin
-8,144.7%
Return on assets
-54.7%
Return on equity
-119%
Return on invested capital
-74.8%
Return on capital employed
-73.6%
Return on sales
-7,554.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
IGMS stock price
How has the IGM Biosciences stock price performed over time
Intraday
4.03%
1 week
12.01%
1 month
8.56%
1 year
333.7%
YTD
116.06%
QTD
8.56%
Financial performance
How have IGM Biosciences's revenue and profit performed over time
Revenue
$2.91M
Gross profit
$2.91M
Operating income
-$237.09M
Net income
-$220.4M
Gross margin
100%
Net margin
-7,571.4%
IGMS's revenue has surged by 74% year-on-year and by 38% since the previous quarter
IGM Biosciences's gross profit has surged by 74% YoY and by 38% QoQ
IGM Biosciences's net margin has increased by 46% YoY and by 33% from the previous quarter
IGMS's operating margin is up by 45% year-on-year and by 32% since the previous quarter
Growth
What is IGM Biosciences's growth rate over time
Valuation
What is IGM Biosciences stock price valuation
P/E
N/A
P/B
8.66
P/S
372.76
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
356.3
The EPS is up by 31% year-on-year and by 15% since the previous quarter
The stock's P/B is 196% above its last 4 quarters average of 2.8 and 66% above its 5-year quarterly average of 5.0
IGM Biosciences's equity has plunged by 53% YoY and by 24% from the previous quarter
IGMS's revenue has surged by 74% year-on-year and by 38% since the previous quarter
IGMS's price to sales (P/S) is 60% more than its last 4 quarters average of 222.8
Efficiency
How efficient is IGM Biosciences business performance
The return on sales is up by 46% year-on-year and by 33% since the previous quarter
IGMS's return on equity is down by 41% year-on-year and by 10% since the previous quarter
The ROA has contracted by 17% YoY
The return on invested capital has declined by 10% year-on-year but it rose by 2.6% since the previous quarter
Dividends
What is IGMS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for IGMS.
Financial health
How did IGM Biosciences financials performed over time
The total assets is 57% greater than the total liabilities
The total assets has declined by 30% year-on-year and by 11% since the previous quarter
IGM Biosciences's current ratio has decreased by 22% YoY and by 12% QoQ
IGM Biosciences's debt is 68% less than its equity
IGMS's debt to equity has soared by 100% YoY and by 28% QoQ
IGM Biosciences's equity has plunged by 53% YoY and by 24% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.